Form 4: Balchem Corp Executive Job Leonard van Gunsteren Reports Stock Option Exercises and Sales
SEC Form 4 Filing
Job Leonard van Gunsteren, SVP and GM of Specialty Products at Balchem Corp, exercised stock options and sold shares on July 31, 2024.
Summary
- On July 31, 2024, Job Leonard van Gunsteren, a Senior Vice President and General Manager at Balchem Corp, executed transactions involving Balchem's common stock.
- Van Gunsteren exercised stock options to acquire 4,000 shares at $58.52 and 3,750 shares at $60.85.
- Following the exercise of these options, he sold 7,750 shares at a weighted average price of $180.0531.
- After these transactions, van Gunsteren directly owns 8,540 shares of Balchem Corp common stock.
Sentiment
Score: 5
Explanation: This is a routine filing of stock transactions by an executive, and doesn't inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Executive stock transactions are common and are closely watched by investors as they can provide insights into an executive's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- It's common for executives at publicly traded companies like Balchem to receive stock options as part of their compensation packages.
- The exercise and sale of these options are governed by SEC regulations to prevent insider trading.
- Comparable companies in the specialty chemicals or ingredients industry, such as Ingredion or Sensient Technologies, also have executives who regularly report similar transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| 02/19/2016 | 20% of stock options ($58.52) vested |
| 02/19/2017 | 40% of stock options ($58.52) vested |
| 02/23/2017 | 20% of stock options ($60.85) vested |
| 02/19/2018 | 40% of stock options ($58.52) vested |
| 02/23/2018 | 40% of stock options ($60.85) vested |
| 02/23/2019 | 40% of stock options ($60.85) vested |
| 02/19/2025 | Expiration date of stock options ($58.52) |
| 02/23/2026 | Expiration date of stock options ($60.85) |
| 07/31/2024 | Date of stock option exercise and sale of shares |
| 08/02/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.